Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | 3.28% | 334.84 | 0.0% | $4823.21m | |
| BNTX | BioNTech SE | 5.41% | 261.09 | 0.0% | $769.86m | |
| NVAX | Novavax, Inc. | 2.66% | 166.25 | 79.4% | $734.23m | |
| AMGN | Amgen, Inc. | -2.27% | 203.13 | 1.4% | $562.61m | |
| SNSS | Sunesis Pharmaceuticals, Inc. | -3.25% | 6.26 | 0.7% | $437.60m | |
| GILD | Gilead Sciences, Inc. | -2.56% | 65.90 | 1.0% | $415.54m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -1.76% | 543.48 | 2.7% | $401.78m | |
| ILMN | Illumina, Inc. | 0.15% | 410.53 | 3.3% | $393.44m | |
| CCXI | ChemoCentryx, Inc. | -5.92% | 32.43 | 2.9% | $364.70m | |
| XLRN | Acceleron Pharma, Inc. | 0.04% | 173.00 | 5.3% | $345.57m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -0.53% | 180.80 | 1.9% | $258.21m | |
| BIIB | Biogen, Inc. | -4.08% | 269.73 | 1.7% | $233.47m | |
| OCGN | Ocugen, Inc. | -4.62% | 8.26 | 0.0% | $170.13m | |
| XENE | Xenon Pharmaceuticals, Inc. | -8.73% | 30.72 | 0.4% | $162.62m | |
| CRSP | CRISPR Therapeutics AG | -0.81% | 96.21 | 0.6% | $151.63m |
Company Profile
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture and marketing of human therapeutics. Its products include the following brands: Aranesp, Aimovig, KANJINTI, EVENITY, AMGEVITA, AVSOLA, BLINCYTO, MVASI, Corlanor, Enbrel, EPOGEN, IMLYGIC, Kyprolis, Neulasta, NEUPOGEN, Nplate, Parsabiv, Prolia, Repatha, Sensipar, Vectibix, Otezla, RIABNI, and XGEVA. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.